Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin versus glipizide in type 2 diabetes mellitus with chronic renal insufficiency
2007-003548-32Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Januvia arm with Glipizide arm (2 arms). Primary endpoints: HbA1c, Incidence of hypoglycemic events and 14 more. Started Aug 2007; status: completed.
02
Drugs
sitagliptinglipizide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-003548-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003548-32.